Changes in the epidemiological patterns of respiratory syncytial virus and human metapneumovirus infection among pediatric patients and their correlation with severe cases: a long-term retrospective study.


Journal

Frontiers in cellular and infection microbiology
ISSN: 2235-2988
Titre abrégé: Front Cell Infect Microbiol
Pays: Switzerland
ID NLM: 101585359

Informations de publication

Date de publication:
2024
Historique:
received: 20 05 2024
accepted: 07 08 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 17 9 2024
Statut: epublish

Résumé

We aim to investigate the prevalence of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) among pediatric patients with acute respiratory tract illness (ARTI) in southern China both pre- and post-COVID-19 pandemic, as well as identify associated risk factors for severe infections. The study conducted a real-time PCR analysis on hospitalized children with ARTI from 2012 to 2023, specifically targeting RSV, hMPV, and other respiratory pathogens. Additionally, demographic data was collected during this analysis. The prevalence of RSV occurs triennially, and likewise, the temporal pattern of hMPV outbreaks mirrors that of RSV. The peak infection rates of RSV and hMPV occurred during and following the implementation of COVID-19 epidemic prevention and control measures. The incidence of RSV infection exhibited bimodal peaks in 2022, while hMPV demonstrated seasonal peaks during the spring, fall, and winter periods post-COVID-19 pandemic. After the COVID-19 outbreak, there has been an upward trend in the proportion of female patients and patients aged one year and older presenting with ARTI, RSV infections, and hMPV infections. Infant (OR = 4.767, 95%CI: [3.888-5.846], The changing epidemiological patterns have the potential to lead to widespread severe outbreaks among children, particularly those with underlying medical conditions who may experience more severe symptoms. Conducting surveillance for

Identifiants

pubmed: 39286815
doi: 10.3389/fcimb.2024.1435294
pmc: PMC11404324
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1435294

Informations de copyright

Copyright © 2024 Kuang, Xu, Wang, Xie, Zhang, Guo, Liang and Zhu.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

N Engl J Med. 2015 Feb 26;372(9):835-45
pubmed: 25714161
JAMA Netw Open. 2022 Jul 1;5(7):e2220949
pubmed: 35816304
Lancet Glob Health. 2021 Jan;9(1):e33-e43
pubmed: 33248481
Clin Infect Dis. 2021 Jun 15;72(12):2199-2202
pubmed: 32986804
Pediatr Infect Dis J. 2013 Aug;32(8):911-4
pubmed: 23429553
MMWR Morb Mortal Wkly Rep. 2023 Apr 07;72(14):355-361
pubmed: 37022977
J Med Virol. 2023 Jul;95(7):e28928
pubmed: 37455559
Emerg Infect Dis. 2022 Jan;28(1):62-68
pubmed: 34932446
J Infect Dis. 2005 Feb 1;191(3):382-6
pubmed: 15633097
J Infect Dis. 2018 Apr 11;217(9):1356-1364
pubmed: 29390105
J Infect Dis. 2002 Nov 1;186(9):1330-4
pubmed: 12402203
BMJ. 2019 Sep 10;366:l5021
pubmed: 31506273
Lancet. 2022 May 28;399(10340):2047-2064
pubmed: 35598608
Euro Surveill. 2022 May;27(19):
pubmed: 35551702
Pediatr Infect Dis J. 2023 Nov 1;42(11):960-964
pubmed: 37523504
Pediatrics. 2016 May;137(5):
pubmed: 27244790
Nat Rev Microbiol. 2023 Mar;21(3):195-210
pubmed: 36253478
Lancet. 2024 Mar 30;403(10433):1241-1253
pubmed: 38367641
J Gen Virol. 2017 Dec;98(12):2912-2913
pubmed: 29087278
PLoS One. 2023 Feb 16;18(2):e0281555
pubmed: 36795639
Eur Respir J. 2008 Aug;32(2):314-20
pubmed: 18448489
Am J Dis Child. 1986 Jun;140(6):543-6
pubmed: 3706232
J Med Virol. 2022 Dec;94(12):5894-5903
pubmed: 35981880
J Infect Dis. 2004 Jul 1;190(1):20-6
pubmed: 15195239
J Infect. 2022 May;84(5):722-746
pubmed: 35123959
MMWR Morb Mortal Wkly Rep. 2022 Oct 07;71(40):1253-1259
pubmed: 36201373
Nat Med. 2001 Jun;7(6):719-24
pubmed: 11385510
Lancet. 2010 May 1;375(9725):1545-55
pubmed: 20399493
N Engl J Med. 2009 Feb 5;360(6):588-98
pubmed: 19196675
J Med Virol. 2008 Apr;80(4):716-23
pubmed: 18297694

Auteurs

Lu Kuang (L)

Center Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Tiantian Xu (T)

Center Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Changbing Wang (C)

Center Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Jiahui Xie (J)

Center Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Yingying Zhang (Y)

Center Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Min Guo (M)

Center Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Zhuofu Liang (Z)

Clinical Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Bing Zhu (B)

Center Laboratory, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH